Form 4: Tyra Biosciences CEO Todd Harris Sells Shares Under 10b5-1 Trading Plan

Tyra Biosciences' CEO, Todd Harris, sold shares of common stock on October 18 and 21, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Todd Harris, the President and CEO of Tyra Biosciences, sold shares of the company's common stock on October 18 and 21, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted in December 2022.
• On October 18, 2024, 43,636 shares were sold at a weighted average price of $27.0143, with individual prices ranging from $26.60 to $27.51.
• On October 21, 2024, two transactions occurred: 5,896 shares were sold at a weighted average price of $27.3204 (ranging from $26.89 to $27.84), and 13,188 shares were sold at a weighted average price of $28.1597 (ranging from $27.8957 to $28.5951).
• Following these transactions, Harris directly owns 1,355,927 shares of Tyra Biosciences common stock.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting stock sales. The use of a 10b5-1 plan mitigates potential negative sentiment, as it indicates pre-planned transactions.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially leading to short-term price fluctuations.

Industry Context

Sales by insiders are a normal part of corporate activity. Investors often look to the reasons behind the sales, such as diversification or planned expenses. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on current inside information.

Comparison to Industry Standards

• Executive stock sales are common in publicly traded companies, especially in the biotech industry where stock options and equity grants are a significant part of compensation.
• The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading, aligning with SEC regulations and industry best practices.
• Comparable companies like Arvinas, Inc. and Relay Therapeutics, Inc. also see regular Form 4 filings from their executives, indicating similar patterns of stock transactions.

Stakeholder Impact

• Shareholders may react to the news of executive stock sales, although the pre-planned nature of the sales under a 10b5-1 plan may lessen any negative impact.
• Employees may be indirectly affected by any stock price fluctuations resulting from the sales.

Key Dates